Suppr超能文献

注射间充质干细胞作为骨髓刺激的补充策略可改善内翻型踝关节骨关节炎行跟骨外侧滑动截骨术后的软骨再生:临床及二次关节镜检查结果

Injection of Mesenchymal Stem Cells as a Supplementary Strategy of Marrow Stimulation Improves Cartilage Regeneration After Lateral Sliding Calcaneal Osteotomy for Varus Ankle Osteoarthritis: Clinical and Second-Look Arthroscopic Results.

作者信息

Kim Yong Sang, Koh Yong Gon

机构信息

Department of Orthopaedic Surgery, Center for Stem Cell & Arthritis Research, Yonsei Sarang Hospital, Seoul, Republic of Korea.

Department of Orthopaedic Surgery, Center for Stem Cell & Arthritis Research, Yonsei Sarang Hospital, Seoul, Republic of Korea.

出版信息

Arthroscopy. 2016 May;32(5):878-89. doi: 10.1016/j.arthro.2016.01.020. Epub 2016 Mar 15.

Abstract

PURPOSE

To compare the clinical and second-look arthroscopic outcomes in patients undergoing arthroscopic marrow stimulation combined with lateral sliding calcaneal osteotomy for varus ankle osteoarthritis, with or without adipose-derived mesenchymal stem cell (MSC) injection.

METHODS

In this retrospective comparative study, 49 patients with varus ankle osteoarthritis underwent second-look arthroscopy after arthroscopic marrow stimulation combined with lateral sliding calcaneal osteotomy between January 2010 and November 2012; 23 ankles underwent marrow stimulation alone (group 1), and 26 underwent marrow stimulation with MSC injection (group 2). The decision whether to receive the MSC injection, which was free of charge, was solely up to the patients. Second-look arthroscopies were performed at a mean of 12.5 months and 12.4 months postoperatively in group 1 and group 2, respectively. Clinical outcome measures included a visual analog scale (VAS) score for pain and the American Orthopaedic Foot & Ankle Society (AOFAS) score. The radiologic outcome variable was the talar tilt angle. On second-look arthroscopy, cartilage regeneration was evaluated using the International Cartilage Repair Society (ICRS) grade.

RESULTS

The mean VAS score improved significantly from 7.3 ± 0.9 to 3.9 ± 1.2 in group 1 and from 7.4 ± 0.8 to 3.1 ± 1.5 in group 2 at final follow-up (P < .001 for both groups). The mean AOFAS score also improved significantly from 64.4 ± 4.1 to 79.6 ± 7.7 in group 1 and from 63.5 ± 4.2 to 84.2 ± 7.9 in group 2 at final follow-up (P < .001 for both groups). The VAS and AOFAS scores were significantly better in group 2 than in group 1 (P = .040 and P = .047, respectively). ICRS grades were significantly correlated with clinical outcomes in both groups (all P < .05), and there were significant differences in ICRS grades between the groups (P < .05). The mean talar tilt angle improved significantly after lateral sliding calcaneal osteotomy in both groups and was significantly correlated with clinical outcomes and ICRS grade (all P < .05).

CONCLUSIONS

In patients with varus ankle osteoarthritis who underwent lateral sliding calcaneal osteotomy, significant improvements in VAS and AOFAS scores, as well as better ICRS grades, were achieved at short-term follow-up after marrow stimulation with additional MSC injection compared with after marrow stimulation alone.

LEVEL OF EVIDENCE

Level III, retrospective comparative study.

摘要

目的

比较接受关节镜下骨髓刺激联合跟骨外侧滑动截骨术治疗内翻型踝关节骨关节炎的患者,在接受或不接受脂肪间充质干细胞(MSC)注射情况下的临床及二次关节镜检查结果。

方法

在这项回顾性比较研究中,49例内翻型踝关节骨关节炎患者于2010年1月至2012年11月期间接受了关节镜下骨髓刺激联合跟骨外侧滑动截骨术,并在术后接受了二次关节镜检查;其中23例踝关节仅接受了骨髓刺激(第1组),26例接受了骨髓刺激并注射了MSC(第2组)。是否接受免费的MSC注射完全由患者自行决定。第1组和第2组分别在术后平均12.5个月和12.4个月进行了二次关节镜检查。临床结果指标包括疼痛视觉模拟量表(VAS)评分和美国矫形足踝协会(AOFAS)评分。放射学结果变量为距骨倾斜角。在二次关节镜检查中,使用国际软骨修复协会(ICRS)分级评估软骨再生情况。

结果

在末次随访时,第1组的平均VAS评分从7.3±0.9显著改善至3.9±1.2,第2组从7.4±0.8显著改善至3.1±1.5(两组P均<.001)。第1组的平均AOFAS评分在末次随访时也从64.4±4.1显著改善至79.6±7.7,第2组从63.5±4.2显著改善至84.2±7.9(两组P均<.001)。第2组的VAS和AOFAS评分显著优于第1组(分别为P = .040和P = .047)。两组的ICRS分级均与临床结果显著相关(所有P<.05),且两组间ICRS分级存在显著差异(P<.05)。两组在跟骨外侧滑动截骨术后平均距骨倾斜角均显著改善,且与临床结果和ICRS分级显著相关(所有P<.05)。

结论

对于接受跟骨外侧滑动截骨术的内翻型踝关节骨关节炎患者,与单纯骨髓刺激相比,在骨髓刺激基础上额外注射MSC后短期随访时,VAS和AOFAS评分有显著改善,ICRS分级也更好。

证据水平

III级,回顾性比较研究。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验